We conducted scRNA-seq on four HCC tissues—two responsive and two non-responsive—to investigate SRSF1 expression in CD8+ T cells during neoadjuvant anti-PD-1 cancer immunotherapy (Supplementary Table 2; Fig. 1i). Here, CD8A is linked to cancer.